tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Matthew L Kaplan - 1734 which are a Buy (83.33%), 347 which are a Hold (16.67%)
Analyst Matthew L Kaplan works at LADENBURG and is covering the Healthcare sector with 63 price targets and ratings displayed on 10 stocks.
Matthew L Kaplan's average stock forecast success ratio is 50.83% with an average time for price targets to be met of 509.6 days.
Most recent stock forecast was given on UTHR, United Therapeutics at 25-Feb-2022.
Analyst best performing recommendations are on TGTX (TG THERAPEUTICS).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS) at 5/12/2020. The price target of $44 was fulfilled within 217 days with a profit of $24.06 (120.66%) receiving and performance score of 5.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
7
$2.69 (62.41%)
7
2 months 16 days ago
2/6 (33.33%)
$1.21 (40.56%)
185
Hold
5
$0.69 (16.01%)
5
3 months 4 days ago
1/3 (33.33%)
$0.61 (17.29%)
15
Buy
3
11 months ago
2/6 (33.33%)
$5.41 (92.85%)
327
Buy
1 years 8 months 14 days ago
1/3 (33.33%)
$5.45 (65.09%)
253
Buy
1
$-3.31 (-76.80%)
2
1 years 8 months 27 days ago
2/2 (100%)
$0.11 (10.64%)
250
What Year was the first public recommendation made by Matthew L Kaplan?
